Introduction
The metabolic syndrome is a cluster of phenotypes that, both individually and collectively, contributes to an elevated risk of cardiovascular disease. A central role for insulin resistance has been postulated for this clustering. Reaven and others have proposed mechanisms whereby either tissue resistance to insulin action, or elevated concentrations of the hormone, might result in the dyslipidaemia, hypertension and alterations in fibrinolysis that comprise the cluster. [1] [2] [3] In recent years, a number of new phenotypes have been added to the cluster, including both microalbuminuria, 4 and elevations of circulating concentrations of fibrinogen 5 and C-reactive protein (CRP). 6 Microalbuminuria is often regarded, at least in diabetic subjects, as a manifestation of endothelial dysfunction, while both fibrinogen and CRP are classic acute-phase proteins. These associations are difficult to explain through mechanisms related to insulin action or inaction. A more plausible explanation is that they represent consequences of a common antecedent, producing on the one hand insulin resistance, and on the other activation of endothelial cells and hepatocytes. Insulin resistance, both in diabetic and nondiabetic subjects, is frequently associated with obesity, and in particular with an excess of central fat. Many of the features that have been ascribed to the metabolic syndrome are more common in obese subjects, including dyslipidaemia, hypertension, elevations in levels of plasminogen activator inhibitor-1 3 and fibrinogen, 5 and microalbuminuria. 7 Furthermore, manifestations of endothelial dysfunction, such as impaired responses to endothelial nitric oxidemediated vasodilators 8 and to shear stress, 9 are found in obese subjects, improving with weight loss. 10 These observations suggest the existence of adipose-generated signals, which influence not only insulin action in skeletal muscle, and both insulin action and acute-phase activation in the liver, but also modulate endothelial cell function in conduit and resistance vessels and in capillaries. A series of studies will be described exploring the relationship between insulin resistance and the metabolic syndrome, endothelial dysfunction, and acute-phase proteins and cytokines. Evidence will be put forward that adipocytegenerated proinflammatory cytokines might provide such signals, and that these could explain the observed links between insulin resistance and vascular disease.
Insulin resistance, endothelial dysfunction and inflammation
In a population study of 107 healthy nondiabetic subjects aged 40-75 years, we have described associations between composite scores for insulin resistance, endothelial dysfunction and acute-phase inflammation. 6 The correlation between the insulin resistance score and the inflammation score was r ¼ 0.59 (Po0.0001). The much weaker relationship between the insulin resistance and endothelial dysfunction scores (r ¼ 0.32) was entirely explained, statistically, by the relationship of each score and that of the acute-phase markers. We have recently described, in 32 nondiabetic Pima Indian subjects, powerful associations of both fasting insulin and clamp-derived measures of insulin action with concentrations of CRP. 11 These observations imply that the inflammatory signals that influence insulin action are, at least in part, accessing the systemic circulation, and so may be acting in endocrine, as well as autocrine/paracrine, fashion.
We have recently conducted a case-control study of middle-aged men with myocardial infarction, where we employed factor analysis to explore clustering of insulin resistance and inflammation variables. 12 Three summary factors emerged, representing insulin resistance, inflammation and blood pressure. We employed a rotation method that allows an exploration of relationships between factors, and found strong and significant correlations between the insulin resistance and the inflammation factor in both cases (r ¼ 0.38) and controls (r ¼ 0.39), with myocardial infarction cases having higher scores for both insulin resistance and inflammation. Again, the associations between the insulin resistance factor and inflammation factor were affected to only a minor degree by adjustment for measures of obesity. Recent data from a study of 37 healthy adult-related clampderived insulin sensitivity and measures of endothelial functional (capillary recruitment 4 min after arterial occlusion as assessed by capillary microscopy) to circulating concentrations of the proinflammatory cytokine tumour necrosis factor-a (TNF-a). 13 Higher levels of TNF-a were related both to impaired insulin sensitivity (r ¼ À0.33, P ¼ 0.05) and to impaired capillary recruitment (r ¼ À0.40, P ¼ 0.02). These observations together suggest that, even in healthy subjects, a state of systemic low-grade inflammation exists and is powerfully associated both with insulin resistance (and the metabolic syndrome) on the one hand, and with endothelial dysfunction or vascular disease on the other.
Determinants of low-grade inflammation in healthy subjects
In our population study of 107 healthy subjects, we explored the possibility that this state of low-grade inflammation might result from asymptomatic infection with several agents implicated in the aetiology of coronary heart disease. 6 However, the relationships between concentrations of circulating inflammatory markers and antibodies to Chlamydia pneumoniae, Helicobacter pylori and cytomegalovirus were weak and inconsistent. We did, however, observe strong correlations between levels of these inflammatory markers and measures of body fat. In the Pima Indian Study, the correlation between levels of CRP and percent body fat measured by DEXA was r ¼ 0.85.
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Using sophisticated clinical physiological techniques, it is possible to study adipose-generated signals by measuring arterio-venous differences across a subcutaneous adipose tissue bed. We have used this method in 27 subjects with a wide range of body mass index, and have found no evidence of secretion of TNF-a from this adipose bed.
14 However, abdominal vein concentrations of interleukin-6 (IL-6) were some 3-4-fold higher than arterial concentrations. If one assumes that IL-6 production is similar in all adipose regions, one can estimate that up to one-third of circulating IL-6 in healthy subjects might derive from adipose tissue. The implication is that obesity is, in itself, a low-grade inflammatory state.
Adipose tissue signalling, insulin resistance and vascular dysfunction
The field of adipose tissue signalling is rapidly expanding. Obesity is accompanied by resistance to insulin action in the liver (supplied mainly by portal blood) and in skeletal muscle (supplied through the systemic circulation), so that any adipose signal should be identifiable without access to the portal circulation. Moreover, the vascular dysfunction of obesity, which can be seen in conduit and resistance vessels in the upper limb, must also be the consequence of a systemic signal from adipose tissue. The insulin resistance of obesity has for many years been attributed to the effects of nonesterified fatty acids (NEFAs), which impair insulin action in both liver and skeletal muscle. 15 Furthermore, the endothelial dysfunction seen in obese subjects may be a consequence of elevated NEFA levels, as a consequence of inhibitory effects on endothelial nitric oxide synthase. 16 More recently, a range of adipose-generated cytokine-like molecules has been identified, collectively termed adipocytokines. As previously outlined, these adipocyte-generated signals may have either local or systemic effects. TNF-a is expressed by adipocytes, and influences insulin signalling through serine phosphorylation of the insulin receptor substrate-1, so inhibiting insulin action at the adipocyte through autocrine and paracrine mechanisms. In the circulation, however, TNF-a appears to be largely bound to specific binding proteins, and so are unlikely to represent an important endocrine signal. 17 IL-6 is an important systemic signal in infections and inflammatory states, this being the major cytokine regulating hepatic production of CRP and other acute-phase proteins. 18 IL-6 shares with TNF-a effects on insulin signalling and glucose transport, which might also result in insulin resistance at myocyte, adipocyte and hepatocyte levels. 19 Furthermore, as a circulating signal of low-grade inflammation, IL-6 may play a role in atherogenesis. Weekly injections of IL-6 into high-fat diet apo-E knockout mice promoted an excessive production of atherosclerotic plaque in these animals. 20 One final candidate for adipose tissue signalling is the adipose-derived protein adiponectin. Several studies have shown that, despite the adipocyte origins of this molecule, levels are inversely related with obesity, and, furthermore, elevating concentrations of the adiponectin homologue in mice has been shown to improve insulin resistance. 21 The control of adiponectin production remains to be investigated, but it is possible that it is subject to negative regulation by one or other adipocytokines acting in autocrine fashion.
Tissue-specific knockouts and integrative physiology
Tissue-specific knockout models provide insights into whole body signalling that can be studied only in intact organisms. Kahn's group has created adipose tissue-specific GLUT-4 knockouts to induce adipose-specific insulin resistance. 22 Although isolated hepatocytes and myocytes from these animals respond normally to insulin, these tissues were substantially resistant to insulin action in vivo. This implies that adipocyte insulin resistance, even if unrelated to insulin signalling pathways or to inflammation, produces insulin resistance in remote tissues. Furthermore, concentrations of NEFAs in these animals were lower than in wild-type mice, suggesting an alternative insulin resistance signal. These models may provide important lessons concerning signalling in whole body physiology.
Conclusion
Obesity appears to be associated with a low-grade state of inflammation, probably in consequence of the secretion of proinflammatory cytokines by adipocytes. These cytokines may underlie many of the components of the insulin resistance syndrome, as well as endothelial dysfunction and, potentially, cardiovascular risk.
